Chart-Typ:
Zeitraum:
| Texxon Holding Limited Announces Financial Results for Fiscal Year 2025 | SHANGHAI, Nov. 18, 2025 /PRNewswire/ -- Texxon Holding Limited (Nasdaq: NPT) (the "Company" or "Texxon"), a leading provider of supply chain management services... ► Artikel lesen |
| D. Boral Capital acted as Sole Bookrunner to Texxon Holding Limited in connection with its ~$11,000,000 Initial Public Offering | NEW YORK CITY, NEW YORK / ACCESS Newswire / October 30, 2025 / On October 23, 2025, Texxon Holding Limited (Nasdaq:NPT) (the "Company" or "Texxon"), a leading provider of supply chain management services... ► Artikel lesen |
| Texxon Holding Limited Announces Closing of $9.5 Million Initial Public Offering | Shanghai, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Texxon Holding Limited (Nasdaq: NPT) (the "Company" or "Texxon"), a leading provider of supply chain management services in the plastics and chemical... ► Artikel lesen |
| ADC Therapeutics SA: ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update | LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026
Recent amendment to HealthCare... ► Artikel lesen |
| ADC Therapeutics SA: ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates | Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash and cash equivalents of approximately... ► Artikel lesen |
| ADC Therapeutics SA: ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large ... | ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated an 89.8% ORR and 77.6% CR across the 49 efficacy-evaluable patients with a minimum of 6 months of... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIVEN ASA finden Sie auf Wallstreet Online.